MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...
Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...
An organization representing foreign service workers said it was "alarmed" by the directive because there could be documents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback